Dafna Yahav
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
Papers in
-
- SARS-CoV-2 and COVID-19 Research 15
- Antimicrobial Resistance in Staphylococcus 12
- Epidemiology 48
- Pneumonia and Respiratory Infections 11
- Co-authors
- Mical Paul (69 shared papers)Leonard Leibovici (60 shared papers)Jihad Bishara (31 shared papers)Noa Eliakim‐Raz (22 shared papers)Abigail Fraser (5 shared papers)Elad Goldberg (18 shared papers)Adi Lador (5 shared papers)Benaya Rozen‐Zvi (14 shared papers)
- Journals
- Clinical Microbiology and Infection (37 papers)European Journal of Clinical Microbiology & Infectious Diseases (12 papers)Journal of Antimicrobial Chemotherapy (12 papers)Infectious Diseases and Therapy (10 papers)Cochrane Database of Systematic Reviews (7 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Dafna Yahav
196 papers receiving 5.6k citations
Dafna Yahav's Hit Papers
Peers
Comparison fields: 5 of 154
- Applied Microbiology and Biotechnology 431
- Molecular Medicine 1.1k
- Microbiology 115
- Infectious Diseases 1.3k
- Clinical Biochemistry 386
Countries citing papers authored by Dafna Yahav
This map shows the geographic impact of Dafna Yahav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dafna Yahav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dafna Yahav more than expected).
Fields of papers citing papers by Dafna Yahav
This network shows the impact of papers produced by Dafna Yahav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dafna Yahav. The network helps show where Dafna Yahav may publish in the future.
Co-authors
The 25 scholars most cited alongside Dafna Yahav, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 214 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New β-Lactam–β-Lactamase Inhibitor Combinations Hit paper breakdown → | 2020 | 379 |
| 2 | 2013 | 231 | |
| 3 | 2011 | 211 | |
| 4 | 2011 | 204 | |
| 5 | 2008 | 198 | |
| 6 | 2007 | 178 | |
| 7 | 2008 | 173 | |
| 8 | 2021 | 173 | |
| 9 | 2021 | 147 | |
| 10 | 2005 | 141 | |
| 11 | 2020 | 132 | |
| 12 | 2018 | 130 | |
| 13 | 2010 | 129 | |
| 14 | How do I manage nocardiosis? Hit paper breakdown → | 2021 | 111 |
| 15 | 2016 | 108 | |
| 16 | 2012 | 104 | |
| 17 | 2015 | 102 | |
| 18 | 2013 | 98 | |
| 19 | 2022 | 98 | |
| 20 | 2009 | 82 |
About Dafna Yahav
Dafna Yahav is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Oncology and Clinical Biochemistry, having authored 214 papers that have together received 5.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (24 papers), Bacterial Identification and Susceptibility Testing (16 papers), Neutropenia and Cancer Infections (15 papers), SARS-CoV-2 and COVID-19 Research (15 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Antibiotic Use and Resistance (12 papers) and Pneumonia and Respiratory Infections (11 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (431 citations), Molecular Medicine (1.1k citations), Microbiology (115 citations), Infectious Diseases (1.3k citations) and Clinical Biochemistry (386 citations). Dafna Yahav has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Mical Paul, Leonard Leibovici, Jihad Bishara, Noa Eliakim‐Raz, Abigail Fraser, Elad Goldberg, Adi Lador, Benaya Rozen‐Zvi, Christian G. Giske and Vincent H. Tam. Their work appears in journals such as Clinical Microbiology and Infection, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy, Infectious Diseases and Therapy and Cochrane Database of Systematic Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.